Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback